Director Thomas E. Chorman of Standex International Corp filed a Form 144 notice of proposed sale of 50 shares of common stock, with an approximate sale date of November 2, 2026, through Fidelity Brokerage Services LLC on the NYSE.

Key Highlights

  • Proposed seller: Thomas E. Chorman, identified in the filing as a Director of Standex International Corp/DE/
  • Shares proposed for sale: 50 shares of common stock with an aggregate market value of $12,500.00
  • Shares outstanding: 12,103,710 shares of common stock reported outstanding
  • Acquisition: The 50 shares were acquired on October 26, 2024, via restricted stock vesting from the issuer, with compensation listed as the nature of payment
  • Rule 10b5-1 plan: The filing indicates a plan adoption date of November 6, 2025
  • Prior three-month sales: Chorman sold 50 shares on August 3, 2026 (gross proceeds $15,278.00), 50 shares on September 1, 2026 (gross proceeds $14,244.50), and 50 shares on October 1, 2026 (gross proceeds $13,569.50)

Standex Director Chorman Files Rule 144 Notice for 50-Share Common Stock Sale

According to the Form 144 filed with the U.S. Securities and Exchange Commission, Thomas E. Chorman, a director of Standex International Corp/DE/ (NYSE:SXI), provided notice of a proposed sale of 50 shares of the company's common stock. The approximate date of sale listed in the filing is November 2, 2026, and the broker named is Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917. The aggregate market value of the proposed sale is stated as $12,500.00.

The filing discloses that the 50 shares subject to the proposed sale were acquired on October 26, 2024, through restricted stock vesting from the issuer. The nature of payment is listed as compensation. The filing also notes that the notice relies on a Rule 10b5-1 plan, with the plan adoption date given as November 6, 2025. The Form 144 was signed by Gary Redman as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Thomas Chorman.

The filing reports three sales of common stock by Chorman during the prior three months: 50 shares sold on August 3, 2026, for gross proceeds of $15,278.00; 50 shares sold on September 1, 2026, for gross proceeds of $14,244.50; and 50 shares sold on October 1, 2026, for gross proceeds of $13,569.50. The issuer's address is listed as 23 Keewaydin Drive, Suite 300, Salem, New Hampshire 03079.

What Was Disclosed

Standex International Corp director Thomas E. Chorman filed a Form 144 notice proposing the sale of 50 shares of common stock on NYSE on approximately November 2, 2026, under a Rule 10b5-1 plan adopted November 6, 2025, with an aggregate market value of $12,500.00.